Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression

PARP抑制剂 三阴性乳腺癌 乳腺癌 DNA损伤 癌症 下调和上调 癌细胞 基因敲除 软膜 雷达51
作者
Xiaobin Ma,Chengxue Dang,Weili Min,Yan Diao,Wentao Hui,Xiaolong Wang,Zhijun Dai,Xi-Jing Wang,Huafeng Kang
出处
期刊:Breast Cancer Research and Treatment [Springer Science+Business Media]
卷期号:176 (1): 109-117 被引量:22
标识
DOI:10.1007/s10549-019-05189-w
摘要

Targeting DNA repair mechanisms to induce apoptosis may be a promising strategy for breast cancer treatment. Olaparib is proved to have anticancer effect by inhibiting DNA repairing protein poly (ADP-ribose) polymerase (PARP). However, the cytotoxicity of olaparib is very limited to homologous recombination-proficient cells. This study aims to examine the effect and mechanism of olaparib treatment in breast cancer cell lines. We investigated the cytotoxic effect of various doses of olaparib treatment to MCF-7 and ZR-75-1 cells in vitro. mRNA and protein levels of PARP and APE1 were examined by real-time PCR and western blot, respectively. APE1-deficient cell lines were created by RNA interference and used for in vitro cytotoxicity study as well as in vivo study. 2 µM or higher concentrations of olaparib lead to significant cell death and ROS production. Moreover, olaparib treatment not only inhibits PARP1, but also reduces the expression of APE1 in both mRNA and protein levels. Deficiency of APE1 resulted in increased sensitivity of MCF-7 and ZR-75-1 cells to olaparib treatment. In vivo study showed that reduction of APE1 significantly reduced the volume and weight of MCF-7 xenografted tumors when treated with olaparib, which suggests the synergistic function of inhibition of APE1 in promoting antitumor effects of olaparib treatment. To acquire better benefits for HR-proficient breast cancer patients, developing chemotherapeutic drugs antagonize APE1 would be an effective strategy to improve the clinical outcome of PARP inhibitors.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
林正心完成签到,获得积分10
1秒前
奇思妙想安德鲁完成签到,获得积分10
2秒前
顾矜的应助被热情的乐荷采纳,获得10
3秒前
9202211125完成签到,获得积分10
3秒前
郭夹心发布了新的文献求助10
3秒前
Akim的应助被一期一会采纳,获得10
3秒前
hmh发布了新的文献求助15
3秒前
水煮电吹风的应助被00hello00采纳,获得10
3秒前
4秒前
drfwjuikesv发布了新的文献求助10
4秒前
5秒前
一米阳光发布了新的文献求助10
5秒前
香蕉觅云的应助被Besttin9799采纳,获得30
5秒前
刘白完成签到,获得积分10
5秒前
Tracy发布了新的文献求助10
5秒前
LIUDAN发布了新的文献求助10
6秒前
7秒前
dieeee完成签到,获得积分10
8秒前
TaoJ的应助被ku采纳,获得10
9秒前
平淡的凌寒完成签到,获得积分10
9秒前
温柔发卡发布了新的文献求助10
9秒前
...完成签到,获得积分10
10秒前
哈基米德发布了新的文献求助10
11秒前
朴实的哲瀚完成签到 ,获得积分20
11秒前
展望未来完成签到 ,获得积分10
13秒前
14秒前
14秒前
小白菜完成签到,获得积分10
15秒前
一个橡果完成签到,获得积分10
15秒前
17秒前
poison完成签到 ,获得积分10
17秒前
17秒前
山海不远发布了新的文献求助30
18秒前
星辰大海的应助被哈基米德采纳,获得10
20秒前
万能图书馆的应助被邱化兴采纳,获得10
20秒前
华仔的应助被Jenson采纳,获得10
21秒前
Besttin9799发布了新的文献求助30
22秒前
22秒前
科研小李发布了新的文献求助10
22秒前
深情安青的应助被smx111采纳,获得20
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183667
求助须知:如何正确求助?哪些是违规求助? 9572953
关于积分的说明 21828185
捐赠科研通 7780853
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558251
邀请新用户注册赠送积分活动 2480500